VALENCIA, Calif. – Dec. 11, 2024 – Nusano, a physics company transforming the production of radioisotopes, today announced it will host a virtual key opinion leader (KOL) panel discussion on Tuesday, December 17, 2024 at 1:00 PM ET to preview the year ahead in...
VALENCIA, Calif. and SYDNEY, Australia – Dec. 9, 2024 – Nusano, a physics company transforming the production of radioisotopes, and GlyTherix Ltd (GlyTherix) an Australian targeted radiotherapy company specializing in developing antibody radiopharmaceuticals for solid...
VALENCIA, Calif. – Dec. 3, 2024 – Nusano, a physics company transforming the production of radioisotopes, today announced the creation of a Medical Radioisotopes Advisory Board. This panel of internationally recognized leaders in nuclear medicine will provide...
VALENCIA, Calif. – November 12, 2024 – Nusano, a physics company transforming the production of radioisotopes, today announced the company’s CEO Chris Lowe will present at William Blair’s Innovators Series: Radiopharmaceuticals virtual event on Thursday, November 14,...
October 29, 2024 – Utah Business’ 2024 class of “Healthcare Heroes” includes one of Nusano’s very own, Greg Moffitt. Greg is the director of Target Development for Nusano. He operates at the forefront of efforts to addressing and solve the...
